Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Myelodysplastic Syndromes 26Leukemia, Myeloid, Acute 24Lymphoma, Non-Hodgkin 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Hodgkin Disease 16Hematologic Neoplasms 16Lymphoma 14Leukemia, Lymphocytic, Chronic, B-Cell 14Multiple Myeloma 11Myeloproliferative Disorders 10Graft vs Host Disease 9Primary Myelofibrosis 8Leukemia, Myelomonocytic, Juvenile 8Lymphoma, Mantle-Cell 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Chronic 6Neoplasms 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myeloid, Accelerated Phase 5Burkitt Lymphoma 5Anemia, Refractory, with Excess of Blasts 5Leukemia, Myeloid, Chronic-Phase 4Congenital Abnormalities 4Blast Crisis 4Waldenstrom Macroglobulinemia 3Neuroblastoma 3

Interventions

Paclitaxel 134Carboplatin 129Bevacizumab 86Gemcitabine 45pembrolizumab 37olaparib 33Cisplatin 30liposomal doxorubicin 29Docetaxel 29Cyclophosphamide 29Topotecan 28niraparib 27Taxes 20Etoposide 18Filgrastim 16Doxorubicin 16Immunoglobulin G 15Disulfides 15apatinib 12Letrozole 12Albumin-Bound Paclitaxel 12Drug Therapy 11fluzoparib 10fludarabine 10Specimen Handling 10Magnetic Resonance Spectroscopy 10Biopsy 10durvalumab 9Nivolumab 9pazopanib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Ovarian Neoplasms × thymoglobulin × Clear all
NCT00523809 2013-01-28

Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor

M.D. Anderson Cancer Center

Phase 2 Terminated
5 enrolled 4 charts
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡